Brain Advance Access published online on September 19, 2006
Brain, doi:10.1093/brain/awl238
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany
* To whom correspondence should be addressed. Mutations in the valosin-containing protein (VCP, p97) gene on chromosome 9p13-p12 cause a late-onset form of autosomal dominant inclusion body myopathy associated with Paget disease of the bone and frontotemporal dementia (IBMPFD). We report on the pathological consequences of three heterozygous VCP (R93C, R155H, R155C) mutations on human striated muscle. IBMPFD skeletal muscle pathology is characterized by degenerative changes and filamentous VCP- and ubiquitin-positive cytoplasmic and nuclear protein aggregates. Furthermore, this is the first report demonstrating that mutant VCP leads to a novel form of dilatative cardiomyopathy with inclusion bodies. In contrast to post-mitotic striated muscle cells and neurons of IBMPFD patients, evidence of protein aggregate pathology was not detected in primary IBMPFD myoblasts or in transient and stable transfected cells using wild-type-VCP and R93C-, R155H-, R155C-VCP mutants. Glutathione S-transferase pull-down experiments showed that all three VCP mutations do not affect the binding to Ufd1, Npl4 and ataxin-3. Structural analysis demonstrated that R93 and R155 are both surface-accessible residues located in the centre of cavities that may enable ligand-binding. Mutations at R93 and R155 are predicted to induce changes in the tertiary structure of the VCP protein. The search for putative ligands to the R93 and R155 cavities resulted in the identification of cyclic sugar compounds with high binding scores. The latter findings provide a novel link to VCP carbohydrate interactions in the complex pathology of IBMPFD.
Received May 10, 2006
Revised July 26, 2006
Accepted August 8, 2006
Article
Pathological consequences of VCP mutations on human striated muscle
Christian U. Hübbers 1 *, Christoph S. Clemen 2 *, Kristina Kesper 3, Annett Böddrich 4, Andreas Hofmann 5, Outi Kämäräinen 5, Karen Tolksdorf 3, Maria Stumpf 1, Julia Reichelt 1, Udo Roth 6, Sabine Krause 7, Giles Watts 8, Virginia Kimonis 8, Mike P. Wattjes 9, Jens Reimann 3, Dietmar R. Thal 10, Katharina Biermann 11, Bernd O. Evert 3, Hanns Lochmüller 7, Erich E. Wanker 4, Benedikt G. H. Schoser 7, Angelika A. Noegel 2, and Rolf Schröder 1 *
2 Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
3 Department of Neurology, University Hospital Bonn, Bonn, Germany
4 Department of Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany
5 Institute of Structural and Molecular Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK
6 Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
7 Friedrich-Baur-Institut and Department of Neurology, Ludwig Maximilians University of Munich, München, Germany
8 Division of Genetics, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
9 Department of Radiology, University Hospital Bonn, Bonn, Germany
10 Institute for Neuropathology, University Hospital Bonn, Bonn, Germany
11 Institute of Pathology, University Hospital Bonn, Bonn, Germany
Rolf Schröder, E-mail: rolf.schroeder{at}uni-koeln.de
Abstract
*These authors have contributed equally to this work.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Halawani, A. C. LeBlanc, I. Rouiller, S. W. Michnick, M. J. Servant, and M. Latterich Hereditary Inclusion Body Myopathy-Linked p97/VCP Mutations in the NH2 Domain and the D1 Ring Modulate p97/VCP ATPase Activity and D2 Ring Conformation Mol. Cell. Biol., August 15, 2009; 29(16): 4484 - 4494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Gitcho, J. Strider, D. Carter, L. Taylor-Reinwald, M. S. Forman, A. M. Goate, and N. J. Cairns VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death J. Biol. Chem., May 1, 2009; 284(18): 12384 - 12398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C C Weihl, P Temiz, S E Miller, G Watts, C Smith, M Forman, P I Hanson, V Kimonis, and A Pestronk TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1186 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Etard, U. Roostalu, and U. Strahle Shuttling of the chaperones Unc45b and Hsp90a between the A band and the Z line of the myofibril J. Cell Biol., March 24, 2008; 180(6): 1163 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Helfrich, J. C. Crockett, L. J. Hocking, and F. P. Coxon The Pathogenesis of Osteoclast Diseases: Some Knowns, but Still Many Unknowns IBMS BoneKEy, February 1, 2007; 4(2): 61 - 77. [Abstract] [Full Text] [PDF]
|
|